432 related articles for article (PubMed ID: 34525962)
1. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
Naendrup JH; Garcia Borrega J; Eichenauer DA; Shimabukuro-Vornhagen A; Kochanek M; Böll B
J Intensive Care Med; 2022 Sep; 37(9):1152-1158. PubMed ID: 34791940
[TBL] [Abstract][Full Text] [Related]
4. [Reactivation of Epstein-Barr virus (
Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
[TBL] [Abstract][Full Text] [Related]
5. Isolation of Epstein-Barr virus-deoxyribonucleic acid in the lower respiratory tract for distinguishing critically ill patients from those with influenza-associated pneumonia: A pilot study.
Bai Y; Guo Y; Chen X; Yang C; Gu L
Clin Respir J; 2023 Dec; 17(12):1246-1253. PubMed ID: 37823412
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 associated EBV reactivation and effects of ganciclovir treatment.
Meng M; Zhang S; Dong X; Sun W; Deng Y; Li W; Li R; Annane D; Wu Z; Chen D
Immun Inflamm Dis; 2022 Apr; 10(4):e597. PubMed ID: 35349757
[TBL] [Abstract][Full Text] [Related]
7. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
Chen T; Song J; Liu H; Zheng H; Chen C
Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
[TBL] [Abstract][Full Text] [Related]
8. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(-) Patients: A Comparative Meta-Analysis.
Manoharan S; Ying LY
Int J Clin Pract; 2023; 2023():1068000. PubMed ID: 36793928
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
10. Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit.
He H; Wang Y; Wu M; Sun B
Clin Respir J; 2017 Nov; 11(6):895-900. PubMed ID: 26663042
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study.
Guiouillier F; Derely J; Salvadori A; Pochard J; Le Goff J; Martinez T; Raffin F; Laitselart P; Beaucreux C; Priou S; Conan PL; Foissaud V; Servonnet A; Vest P; Boutonnet M; de Rudnicki S; Bigaillon C; Libert N
Intensive Care Med; 2024 Mar; 50(3):418-426. PubMed ID: 38436725
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Coinfection in COVID-19.
Nadeem A; Suresh K; Awais H; Waseem S
J Investig Med High Impact Case Rep; 2021; 9():23247096211040626. PubMed ID: 34428954
[TBL] [Abstract][Full Text] [Related]
13. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19.
Simonnet A; Engelmann I; Moreau AS; Garcia B; Six S; El Kalioubie A; Robriquet L; Hober D; Jourdain M
Infect Dis Now; 2021 May; 51(3):296-299. PubMed ID: 33495765
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis.
Hu J; Zhang X; Yu G; Cai H; Gu J; Hu M; Xiang D; Lian J; Yu L; Jia H; Zhang Y; Yang Y
BMC Gastroenterol; 2019 Jun; 19(1):94. PubMed ID: 31215410
[TBL] [Abstract][Full Text] [Related]
17. [Lung injury associated with severe Epstein-Barr virus (EBV) infection].
Cui Y; Zhang Y; Wang F; Zhu Y; Chen R; Xu L
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):586-91. PubMed ID: 26717656
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus and cytomegalovirus coinfection in Egyptian COVID-19 patients.
Barakat EF; Sherief AF; Elsheikh NG; Khalifa MMME
Egypt Liver J; 2023; 13(1):27. PubMed ID: 37250271
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
20. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.
Paolucci S; Cassaniti I; Novazzi F; Fiorina L; Piralla A; Comolli G; Bruno R; Maserati R; Gulminetti R; Novati S; Mojoli F; Baldanti F;
Int J Infect Dis; 2021 Mar; 104():315-319. PubMed ID: 33359064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
